AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Laxsita MF 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Laxian Healthcare

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Laxsita MF 50mg/500mg Tablet

Diabexe Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risks. Diabexe Duo may be used independently or with other diabetes treatments. Optimal results require a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Taking it with food minimizes stomach upset. Consistent daily use at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol use before starting. Pregnant or breastfeeding individuals must consult their physician. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol consumption should be minimized due to its blood sugar-lowering effect. Your physician will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Laxsita MF 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Laxsita MF 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Laxsita MF 50mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Laxsita MF 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Laxsita MF 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Laxsita MF 50mg/500mg tablet should be administered with a meal.

How Laxsita MF 50mg/500mg Tablet works:

Combining sitagliptin 50mg and metformin 500mg, Laxsita MF tablets manage blood glucose levels through a dual mechanism. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This synergistic action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Laxsita MF 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Laxsita MF 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Laxsita MF 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Laxsita MF 50mg/500mg Tablets, potentially requiring dosage modification. Consultation with a physician is necessary. The use of Laxsita MF 50mg/500mg Tablets is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Laxsita MF 50mg/500mg tablets is potentially hazardous for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Laxsita MF 50mg/500mg Tablet :

Should you forget a dose of Laxsita MF 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Laxsita MF 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Laxsita MF 50mg/500mg Tablet

Laxsita MF 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Laxsita MF 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Laxsita MF 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Laxsita MF 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Laxsita MF 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Laxsita MF 50mg/500mg Tablets. This rare complication is more likely in individuals with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Laxsita MF 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Laxsita MF 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Laxsita MF 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Laxsita MF 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Laxsita MF 50mg/500mg Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Laxsita MF 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Laxsita MF 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Laxsita MF 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Laxsita MF 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Laxsita MF 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Laxsita MF 50mg/500mg Tablet. This rare complication is avoided in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Laxsita MF 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Laxsita MF 50mg/500mg Tab...
171
MRP 198
13% off